After our last session in STING, where we defined better the problems we are trying to solve, our favorite customer and what would be our value proposition, we are aiming to define the channels in which we would make our product available, and how.
Also, following the Lean Startup methodology, we are aiming to define our first Minimum Viable Product, or MVP.
The MVP is a product with the minimum features in order to gather validated learnings about our product and its continued development. Not only gathering insights from an MVP is often less expensive than developing a product with more features, but also has the great advantage of versatility, as it permits to rapidly follow the build → measure → learn cycle.
Of course, validating learnings through an MVP avoids the increased costs and risks if the product fails, for example, due to incorrect assumptions, if we were building it for months without testing our hypothesis. A significative difference between an MVP and a prototype is that we are also aiming to test the business viability of our product (although we would probably won’t make a profit out of it… yet!).
It is also very enjoyable to have the company of Team O with us at Fleminsberg, as we develop our first MVP conception. It is always good to test how crazy our ideas can be, from people that have walked the Clinical Innovation Fellowships with us!
(You can always reach us by sending an e-mail to: firstname.lastname@example.org)
José (Team Infection)